Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Inge Vangenechten"'
Autor:
Inge Vangenechten, Petr Smejkal, Jiri Zavrelova, Ondrej Zapletal, Alexander Wild, Jan Jacques Michiels, Zwi Berneman, Jan Blatny, Angelika Batorova, Tatiana Prigancova, Miroslav Penka, Alain Gadisseur
Publikováno v:
TH Open, Vol 06, Iss 04, Pp e335-e346 (2022)
Background von Willebrand disease (VWD) is a genetic bleeding disorder caused by defects of von Willebrand factor (VWF), quantitative (type 1 and 3) or qualitative (type 2). The laboratory phenotyping is heterogenic making diagnosis difficult. Object
Externí odkaz:
https://doaj.org/article/75dd3755ee8443b3a845469109e1de0d
Autor:
Inge Vangenechten, Alain Gadisseur
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 6, Pp 1024-1034 (2020)
Abstract Background Phenotypic von Willebrand disease (VWD) classification requires multiple tests including analysis of multimeric distributions von Willebrand factor (VWF) and evaluation of its structure. VWF multimer analysis is labor intensive, n
Externí odkaz:
https://doaj.org/article/9ba87f4059994762b1277fcf8944c643
Autor:
Tereza Fidalgo, Ulrich Budde, Tatiana Prigancova, Jan Jacques Michiels, Angelika Batorova, Inge Vangenechten, Miroslav Penka, Francisco Javier Battle, Alain Gadisseur, D. Flemming Hansen, Petr Smejkal, Jan Blatny
Publikováno v:
Acta Scientific Medical Sciences. 3:140-158
The FVIII binding site on von Willebrand factor (VWF) is located in the D’ (766-864) and D3 (1054-1060) regions of the VWF gene. The cysteine residues in the D’ domain form disulfide bridges within the D’ trypsin-inhibitor-like (TIL’) and E
Autor:
Inge Vangenechten, Jan Jacques Michiels, Ondrej Zapletal, Petr Smejkal, Miroslav Penka, Jiri Zavrelova, Zwi N. Berneman, Alain Gadisseur, Jan Blatný
Publikováno v:
Thrombosis and haemostasis : international journal for vascular biology and medicine
Background von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative (type 1 and 3) or qualitative (type 2) defect of von Willebrand factor (VWF). The heterogeneity of laboratory phenotyping makes diagnosing difficult. O
Autor:
Jan Jacques Michiels, Petr Smejkal, Ulrich Budde, Alain Gadisseur, Tatiana Pricangova, Inge Vangenechten, Angelika Batorova, Miroslav Penka
Publikováno v:
Clinical and applied thrombosis/hemostasis
The European Clinical Laboratory and Molecular (ECLM) classification of von Willebrand disease (vWD) is based on the splitting approach which uses sensitive and specific von Willebrand factor (vWF) assays with regard to the updated molecular data on
Autor:
Petr Smejkal, Jan Jacques Michiels, Zwi N. Berneman, K. Mayger, Inge Vangenechten, Ulrich Budde, Jan Blatny, Miroslav Penka, Alain Gadisseur, Gary W. Moore
Publikováno v:
International Journal of Clinical and Experimental Medical Sciences. 5:80
A complete set of rapid activity and classical von Willebrand factor (VWF) assays for Willebrand disease (VWD) diagnosis was used in the present study to characterize VWD type 1, 2A, 2B and 2M patients due to mutations in the A1, A2 and A3 domains. T
Autor:
Inge Vrelust, Marc Van der Planken, Inge Vangenechten, Reinhard Schneppenheim, Alain Gadisseur
Publikováno v:
Thrombosis and Haemostasis. 98:464-466
Identification of a novel candidate splice site mutation (0874+1G>A) in a type 3 von Willebrand disease patient
Autor:
Alain Gadisseur, Inge Vangenechten, Angelika Batorova, Miroslav Penka, Petr Smejkal, Jan Jacques Michiels, Tatiana Prigancova
Publikováno v:
World Journal of Hematology. 5:61
Changing insights in the diagnosis and classification of autosomal recessive and dominant von Willebrand diseases 1980-2015
Autor:
Alain P, Gadisseur, Inge, Vrelust, Inge, Vangenechten, Reinhard, Schneppenheim, Marc, Van der Planken
Publikováno v:
Thrombosis and haemostasis. 98(2)
Publikováno v:
Thrombosis and haemostasis : international journal for vascular biology and medicine
Successful pregnancy in a patient with factor V deficiency: Case report and review of the literature